We are live on ! Find out more
PM

Pembroke Management Portfolio holdings

AUM $774M
1-Year Est. Return 40.73%
This Fund
S&P 500
This Quarter Est. Return
+21.23%
1 Year Est. Return
+40.73%
3 Year Est. Return
+94.47%
5 Year Est. Return
+109.57%
10 Year Est. Return
+778.41%
AUM
$774M
AUM Growth
+$82.3M
Cap. Flow
-$24.7M
Cap. Flow %
-3.19%
Top 10 Hldgs %
42.82%
Holding
112
New
15
Increased
22
Reduced
59
Closed
12

Top Buys

Rank Stock Value
1
VSEC icon
VSE Corp
VSEC
+$19.2M
2
OLLI icon
Ollie's Bargain Outlet
OLLI
+$15.6M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$9.49M
4
TKR icon
Timken Company
TKR
+$8.93M
5
SAIA icon
Saia
SAIA
+$5.97M

Top Sells

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$19.5M
2
MDA
MDA Space Ltd
MDA
+$16.9M
3
AAON icon
Aaon
AAON
+$15.6M
4
WK icon
Workiva
WK
+$13.4M
5
CNM icon
Core & Main
CNM
+$13.3M

Sector Composition

Rank Sector Weight
1 Industrials 37.18%
2 Technology 17.33%
3 Consumer Discretionary 14.77%
4 Financials 10.07%
5 Healthcare 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
101
Boston Scientific
BSX
$67.9B
-3,736
Closed -$234K
CHWY icon
102
Chewy
CHWY
$9.52B
-160,327
Closed -$4.33M
CSGP icon
103
CoStar Group
CSGP
$13.1B
-5,241
Closed -$211K
CWST icon
104
Casella Waste Systems
CWST
$5.96B
-17,073
Closed -$1.35M
GIB icon
105
CGI
GIB
$15.5B
-14,220
Closed -$1.04M
LCII icon
106
LCI Industries
LCII
$2.5B
-42,026
Closed -$5.17M
QTWO icon
107
Q2 Holdings
QTWO
$4.06B
-91,885
Closed -$4.35M
STN icon
108
Stantec
STN
$8.41B
-6,933
Closed -$599K
STVN icon
109
Stevanato
STVN
$5.74B
-150,818
Closed -$2.07M
TECH icon
110
Bio-Techne
TECH
$11.3B
-372,325
Closed -$19.5M
VEEV icon
111
Veeva Systems
VEEV
$44.9B
-1,218
Closed -$214K
WK icon
112
Workiva
WK
$4.31B
-224,900
Closed -$13.4M

Similar funds

Pembroke Management's Q2 2026 Portfolio in Review

As of Q2 2026, Pembroke Management held 112 positions worth $774M, up 12% from $691M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pembroke Management withdrew a net $24.7M in Q2 2026, closing 12 positions and reducing 59 holdings. Its most notable exit was Bio-Techne, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 37% of assets, down from 38% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Pembroke Management opened a new position in Ligand Pharmaceuticals worth $12.7M.

  • Pembroke Management's largest Q2 2026 buy was Ligand Pharmaceuticals: 40,277 shares worth $12.7M.
  • Pembroke Management added most to VSE Corp in Q2 2026, an estimated $19.2M increase.
  • Pembroke Management's biggest Q2 2026 reduction was MDA Space Ltd, cutting an estimated $16.9M.
  • Pembroke Management fully exited Bio-Techne in Q2 2026, selling an estimated $19.5M.
  • Pembroke Management's ten largest holdings make up 43% of its $774M portfolio in Q2 2026.
  • Pembroke Management opened 15 new positions and closed 12 in Q2 2026.
  • Pembroke Management's portfolio value rose 12% quarter-over-quarter to $774M.

Based on Pembroke Management's 13F filing for Q2 2026, filed 22 Jul 2026.